Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Stanley Berger currently holds 21,692 shares of Actinium Pharmaceuticals, Inc. (ATNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Stanley Berger has been a net buyer of ATNM stock. They have purchased $5.5K and sold $0 worth of shares.
Mark Stanley Berger's most recent insider trade was on Feb 27, 2026, when they sold 7,168 shares at $2.00 per share.
Mark Stanley Berger serves as Executive at Actinium Pharmaceuticals, Inc. (ATNM). They have executed 8 insider transactions totaling $5.5K over their tenure at the company.
Mark Stanley Berger holds the position of Executive at Actinium Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Mark Stanley Berger has shown a buying trading pattern, with $5.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark Stanley Berger was on Feb 27, 2026, when they sold $14.3K worth of GNPX shares. This transaction involved 7,168 shares at $2.00 per share.
Mark Stanley Berger currently owns 21,692 shares of Actinium Pharmaceuticals, Inc. (ATNM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Stanley Berger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Stanley Berger has 8 Form 4 filings on record as an insider at Actinium Pharmaceuticals, Inc..
Set alerts for Mark Stanley Berger and 40,000+ other insiders.